The Claim
In ovariectomized female rats, administration of 8-prenylnaringenin at a dose of 15 mg/kg for three days results in a greater increase in the number of terminal end buds (TEB) in the mammary gland compared to either 6-DMAN or naringenin treatment.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Scientists found that giving a plant compound called 8-prenylnaringenin to female rats without ovaries, at a specific dose for three days, made more little bud-like structures grow in their mammary glands than two other similar compounds did.
See the scientific wording
In ovariectomized female rats, 8-prenylnaringenin at 15 mg/kg administered for three days increases the number of terminal end buds (TEB) in the mammary gland more than 6-DMAN or naringenin
What the research says
1 studyThe study gave 8-prenylnaringenin to rats with their ovaries removed and found it increased the number of terminal end buds in the mammary gland more than the other two compounds tested (6-DMAN and naringenin), exactly matching what the claim says.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.